Menus Subscribe Search

Follow us


science-patient

(PHOTO: EVERETT COLLECTION/SHUTTERSTOCK)

Selling Your Body to Science

• September 03, 2013 • 10:00 AM

(PHOTO: EVERETT COLLECTION/SHUTTERSTOCK)

Medical research depends on human subjects, but should we pay people to be our guinea pigs?

In the back halls of any academic medical center, you’ll find notice boards covered with an assortment of flyers offering money to those willing to participate in medical studies. As a cash-strapped graduate student, I would scan these notices, looking for studies that offered a few hundred dollars in exchange for doing something that didn’t sound too unbearable. I wanted to supplement my meager graduate school stipend, and I had a few resources I could exchange for cash: my blood, my tissues, my immune system, and my tolerance for pain.

The ethics of paying people to volunteer as medical research subjects have been a source of controversy for decades. The primary concern is that money often warps people’s judgment when it comes to assessing risk. Bioethicists worry that a cash offer is an “undue inducement” that will cause low-income people to ignore the risks of a study and compromise their ability to give fully-informed consent. While researchers and institutional ethics committees may see these payments as a benefit that justifies riskier studies.

People who consent to participate in unspecified future studies can’t possibly know in advance what risks they’re exposing themselves to.

Despite bioethicists debating whether and how much human subjects should be paid, academic medical centers and pharmaceutical companies have generally forged ahead and done whatever’s been needed to recruit enough participants for their studies. The results have sometimes been ugly, like when pharmaceutical company Eli Lilly paid homeless alcoholics to participate in safety testing of new drugs.

In a 2011 paper, California bioethicists Ari VanderWalde and Seth Kurzban reviewed the contentious ethical history of paying human subjects and took stock of where things stand now. They argued that the lack of consensus among bioethicists has resulted in an ad hoc, patchwork system that leaves too much up to the individual researchers, who may have good intentions but are “likely to subconsciously exploit, coerce, and put subject health at risk.”

They concluded that, despite disagreement among bioethicists, research institutions are not going to stop using money as a recruitment tool any time soon, and there seems to be no shortage of people willing to sell their bodies to science—human subjects even have their own jobzine, Guinea Pig Zero. The main task now is to work out the ethical framework that should guide these payments, so that subjects are compensated fairly for their efforts, and so that financial incentives don’t hinder their ability to make an informed assessment of the study risks.

UNFORTUNATELY, THE RECENT EXPLOSION in the number of human genetic studies means that an informed risk assessment may no longer be possible. Driven by technological advances in DNA analysis, human genetic studies generate an insatiable demand for human subjects, which has led to a rise in so-called biobanks, which store hundreds of thousands of tissue and genetic samples that can be used in future research. For statistical reasons, human genetic studies often require a very large number of subjects, which means it’s too expensive and time consuming to recruit subjects from scratch for every study. Instead, researchers share samples and data through biobanks and databases like the National Institutes of Health’s database of Genotypes and Phenotypes.

Human subjects are now frequently asked to consent not just to the procedures and risks of a single study, but also to broadly consent to the use of their samples in completely unrelated future studies by different research teams. This kind of broad consent is a new beast on the ethical landscape: people who consent to participate in unspecified future studies can’t possibly know in advance what risks they’re exposing themselves to.

The risks of these future studies obviously aren’t the kind of physical risk that, say, a drug trial involves, but they can still be serious. One very extensive genetic study, the Personal Genomes Project, lists what your genetic data could expose you to: “Anyone with sufficient knowledge” could take that data and “infer paternity or other features of the participant’s genealogy,” “claim relatedness to criminals or incriminate relatives,” or even “make synthetic DNA corresponding to the participant and plant it at a crime scene.”

So what ethical principles should guide payments to human research subjects whose samples might be biobanked, freely shared among researchers, and used in future genetic studies? It’s an issue that has hardly been addressed yet, perhaps because, as some researchers have remarked, “the empirical facts of the genomic science change too fast for the reflections of ethics to keep pace with.” But we have an acute need to set up a consistent ethical framework that can help researchers and institutional ethics committees resolve the tension between the need to share scientific resources and the responsibility to protect the people who put themselves at risk for medical research. If bioethicists and funding agencies don’t get ahead on this issue, individual researchers and institutions will resolve it in their own way, establishing practices that will be hard to change later. Without a uniform framework to guide how we use money as a recruiting tool, we’ve experienced some major ethical lapses in drug trials and traditional medical studies. With genetic studies, we’re at risk for ethical lapses on an even grander scale.

Michael White
Michael White is a systems biologist at the Department of Genetics and the Center for Genome Sciences and Systems Biology at the Washington University School of Medicine in St. Louis, where he studies how DNA encodes information for gene regulation. He co-founded the online science pub The Finch and Pea. Follow him on Twitter @genologos.

More From Michael White

A weekly roundup of the best of Pacific Standard and PSmag.com, delivered straight to your inbox.

Recent Posts

October 24 • 4:00 PM

We Need to Normalize Drug Use in Our Society

After the disastrous misconceptions of the 20th century, we’re returning to the idea that drugs are an ordinary part of life experience and no more cause addiction than do other behaviors. This is rational and welcome.


October 24 • 2:00 PM

A Letter to the Next Attorney General: Fix Presidential Pardons

More than two years ago, a series showed that white applicants were far more likely to receive clemency than comparable applicants who were black. Since then, the government has spent hundreds of thousands of dollars on a study, but the pardons system remains unchanged.


October 24 • 12:00 PM

What Makes You So Smart, Middle School Math Teacher?

Noah Davis talks to Vern Williams about what makes middle school—yes, middle school—so great.


October 24 • 10:00 AM

Why DNA Is One of Humanity’s Greatest Inventions

How we’ve co-opted our genetic material to change our world.


October 24 • 8:00 AM

What Do Clowns Think of Clowns?

Three major players weigh in on the current state of the clown.


October 24 • 7:13 AM

There Is No Surge in Illegal Immigration

The overall rate of illegal immigration has actually decreased significantly in the last 10 years. The time is ripe for immigration reform.


October 24 • 6:15 AM

Politicians Really Aren’t Better Decision Makers

Politicians took part in a classic choice experiment but failed to do better than the rest of us.


October 24 • 5:00 AM

Why We Gossip: It’s Really All About Ourselves

New research from the Netherlands finds stories we hear about others help us determine how we’re doing.


October 24 • 2:00 AM

Congratulations, Your City Is Dying!

Don’t take population numbers at face value.


October 23 • 4:00 PM

Of Course Marijuana Addiction Exists

The polarized legalization debate leads to exaggerated claims and denials about pot’s potential harms. The truth lies somewhere in between.


October 23 • 2:00 PM

American Companies Are Getting Way Too Cozy With the National Security Agency

Newly released documents describe “contractual relationships” between the NSA and U.S. companies, as well as undercover operatives.


October 23 • 12:00 PM

The Man Who’s Quantifying New York City

Noah Davis talks to the proprietor of I Quant NY. His methodology: a little something called “addition.”


October 23 • 11:02 AM

Earliest High-Altitude Settlements Found in Peru

Discovery suggests humans adapted to high altitude faster than previously thought.


October 23 • 10:00 AM

The Psychology of Bribery and Corruption

An FBI agent offered up confidential information about a political operative’s enemy in exchange for cash—and they both got caught. What were they thinking?


October 23 • 8:00 AM

Ebola News Gives Me a Guilty Thrill. Am I Crazy?

What it means to feel a little excited about the prospect of a horrific event.


October 23 • 7:04 AM

Why Don’t Men Read Romance Novels?

A lot of men just don’t read fiction, and if they do, structural misogyny drives them away from the genre.


October 23 • 6:00 AM

Why Do Americans Pray?

It depends on how you ask.


October 23 • 4:00 AM

Musicians Are Better Multitaskers

New research from Canada finds trained musicians more efficiently switch from one mental task to another.


October 22 • 4:00 PM

The Last Thing the Women’s Movement Needs Is a Heroic Male Takeover

Is the United Nations’ #HeForShe campaign helping feminism?


October 22 • 2:00 PM

Turning Public Education Into Private Profits

Baker Mitchell is a politically connected North Carolina businessman who celebrates the power of the free market. Every year, millions of public education dollars flow through Mitchell’s chain of four non-profit charter schools to for-profit companies he controls.


October 22 • 12:00 PM

Will the End of a Tax Loophole Kill Off Irish Business and Force Google and Apple to Pay Up?

U.S. technology giants have constructed international offices in Dublin in order to take advantage of favorable tax policies that are now changing. But Ireland might have enough other draws to keep them there even when costs climb.


October 22 • 10:00 AM

Veterans in the Ivory Tower

Why there aren’t enough veterans at America’s top schools—and what some people are trying to do to change that.


October 22 • 8:00 AM

Our Language Prejudices Don’t Make No Sense

We should embrace the fact that there’s no single recipe for English. Making fun of people for replacing “ask” with “aks,” or for frequently using double negatives just makes you look like the unsophisticated one.


October 22 • 7:04 AM

My Politicians Are Better Looking Than Yours

A new study finds we judge the cover by the book—or at least the party.


October 22 • 6:00 AM

How We Form Our Routines

Whether it’s a morning cup of coffee or a glass of warm milk before bed, we all have our habitual processions. The way they become engrained, though, varies from person to person.


Follow us


Politicians Really Aren’t Better Decision Makers

Politicians took part in a classic choice experiment but failed to do better than the rest of us.

Earliest High-Altitude Settlements Found in Peru

Discovery suggests humans adapted to high altitude faster than previously thought.

My Politicians Are Better Looking Than Yours

A new study finds we judge the cover by the book—or at least the party.

That Cigarette Would Make a Great Water Filter

Clean out the ashtray, add some aluminum oxide, and you've (almost) got yourself a low-cost way to remove arsenic from drinking water.

Love and Hate in Israel and Palestine

Psychologists find that parties to a conflict think they're motivated by love while their enemies are motivated by hate.

The Big One

One company, Amazon, controls 67 percent of the e-book market in the United States—down from 90 percent five years ago. September/October 2014 new-big-one-5

Copyright © 2014 by Pacific Standard and The Miller-McCune Center for Research, Media, and Public Policy. All Rights Reserved.